Imperagen

Imperagen

BiotechManchester, United Kingdom

Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.

$6.7M · SeedVisit website ↗

🏆 Featured in Datapile’s Q2 2026 UK Funding Report

Read the Q2 2026 UK report →
Add this badge to your site
Featured in Datapile’s Q2 2026 UK Funding Report
<a href="https://datapile.co/reports/q2-2026-uk-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 UK Funding Report</a>

Funding history

  1. $6.7MSeed2026-05-21
    Source: news.google.com ↗

Founder

Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond
Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond
Co-founders

Investors in Imperagen

Backers from this company's tracked funding rounds.

  • PXN Ventures
  • IQ Capital
  • Northern Gritstone

Related on Datapile